MGCLD Stock Price, News & Analysis
mgcld
Company Description
Argent BioPharma, formerly known as MGC Pharmaceuticals Ltd, is a key player in the biopharmaceutical industry, focusing on Polypharmacology and Nanotechnology. With a strategic focus on developing therapies targeting multiple molecular targets, the company aims to address complex diseases and enhance therapeutic outcomes. Operating in major markets like the UK, USA, and Europe, Argent BioPharma is committed to advancing its product portfolio in immunology and neurology. Through innovative treatments like CannEpil® for epilepsy and CogniCann® for dementia, the company aims to meet urgent medical needs and drive global healthcare accessibility.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding
SEC Filings
No SEC filings available for MGCLD.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is Argent BioPharma's core focus?
Argent BioPharma focuses on Polypharmacology and Nanotechnology in the biopharmaceutical industry.
Where does Argent BioPharma operate?
The company operates in major markets like the UK, USA, and Europe.
What are some of Argent BioPharma's leading products?
Some of the leading products include CannEpil® for epilepsy and CogniCann® for dementia.
What is Argent BioPharma's vision?
The company aims to become a globally recognized leader in the biopharmaceutical industry.
How does Argent BioPharma contribute to healthcare accessibility?
Argent BioPharma aims to develop innovative treatments to address global health challenges.
What are the core values of Argent BioPharma?
The company's core values include integrity, diversity, teamwork, accountability, and excellence.
What strategic pillars guide Argent BioPharma's mission?
The strategic pillars include pioneering life science innovations, global accessibility, consistent innovation, and industry leadership.
What are the key achievements of Argent BioPharma?
The company has rebranded to Argent BioPharma and is poised for growth in the biopharmaceutical industry.
How does Argent BioPharma innovate in drug development?
The company uses Polypharmacology to create therapies targeting multiple molecular targets.
What is the commitment of Argent BioPharma to patient care?
Argent BioPharma is committed to meeting urgent unmet medical needs through innovative treatments.